{"id":"https://openalex.org/W2416610729","doi":null,"title":"Attainment of diabetes-related quality measures with canagliflozin versus sitagliptin.","display_name":"Attainment of diabetes-related quality measures with canagliflozin versus sitagliptin.","alternate_titles":[],"publication_year":2014,"publication_date":"2014-01-01","ids":{"openalex":"https://openalex.org/W2416610729","mag":"2416610729","pmid":"https://pubmed.ncbi.nlm.nih.gov/24512193"},"language":"en","primary_location":{"id":"pmid:24512193","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24512193","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American journal of managed care","raw_type":"Clinical Trial, Phase III"},"parent_works":[],"lineage":["https://openalex.org/W2416610729"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103402778","display_name":"Robert A. Bailey","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Robert A Bailey","raw_affiliation_strings":["1000 US Route 202 South, Raritan, NJ 08869. E-mail: rbailey5@its.jnj.com","1000 US Route 202 South, Raritan, NJ 08869. E-mail:"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1000 US Route 202 South, Raritan, NJ 08869. E-mail: rbailey5@its.jnj.com","institution_ids":[]},{"raw_affiliation_string":"1000 US Route 202 South, Raritan, NJ 08869. E-mail:","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061179417","display_name":"ChandrasekharRao Venkata Damaraju","orcid":"https://orcid.org/0000-0003-4925-4987","observed_orcids":["https://orcid.org/0000-0003-4925-4987"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C V Damaraju","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103688609","display_name":"Silas C Martin","orcid":"https://orcid.org/0009-0003-6117-2519","observed_orcids":["https://orcid.org/0009-0003-6117-2519"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Silas C Martin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110257714","display_name":"Gary E. Meininger","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gary E Meininger","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112780729","display_name":"Marcia F.T. Rupnow","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marcia F T Rupnow","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5070289715","display_name":"Lawrence Blonde","orcid":"https://orcid.org/0000-0003-0492-6698","observed_orcids":["https://orcid.org/0000-0003-0492-6698"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lawrence Blonde","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.8166,"has_fulltext":false,"cited_by_count":19,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.90094687,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"20","issue":"1 Suppl","first_page":"s16","last_page":"s24"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/canagliflozin","display_name":"canagliflozin","score":0.9959999918937683},{"id":"https://openalex.org/keywords/sitagliptin","display_name":"sitagliptin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.996999979019165},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.8690000176429749},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.8349999785423279},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.9359999895095825},{"id":"https://openalex.org/keywords/blood-pressure","display_name":"blood pressure","score":0.7910000085830688},{"id":"https://openalex.org/keywords/ldl-cholesterol","display_name":"LDL cholesterol","score":0.996999979019165},{"id":"https://openalex.org/keywords/body-mass-index","display_name":"body mass index","score":0.9169999957084656},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.9829999804496765},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.6069999933242798},{"id":"https://openalex.org/keywords/sulfonylureas","display_name":"sulfonylureas","score":0.9739999771118164},{"id":"https://openalex.org/keywords/quality-of-care-measures","display_name":"quality of care measures","score":0.6150000095367432},{"id":"https://openalex.org/keywords/composite-endpoints","display_name":"composite endpoints","score":0.6050000190734863},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.47600001096725464},{"id":"https://openalex.org/keywords/overweight-patients","display_name":"overweight patients","score":0.4519999921321869},{"id":"https://openalex.org/keywords/antidiabetic-drug-comparison","display_name":"antidiabetic drug comparison","score":0.46399998664855957}],"concepts":[{"id":"https://openalex.org/C2779284873","wikidata":"https://www.wikidata.org/wiki/Q419832","display_name":"Sitagliptin","level":4,"score":0.946194052696228},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9262008666992188},{"id":"https://openalex.org/C2777451236","wikidata":"https://www.wikidata.org/wiki/Q5030940","display_name":"Canagliflozin","level":4,"score":0.9198636412620544},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.6845909357070923},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6495746970176697},{"id":"https://openalex.org/C2777538456","wikidata":"https://www.wikidata.org/wiki/Q311213","display_name":"Glycated hemoglobin","level":4,"score":0.6422955393791199},{"id":"https://openalex.org/C2780221984","wikidata":"https://www.wikidata.org/wiki/Q131191","display_name":"Body mass index","level":2,"score":0.6150871515274048},{"id":"https://openalex.org/C67761136","wikidata":"https://www.wikidata.org/wiki/Q2105849","display_name":"Post-hoc analysis","level":2,"score":0.5976505279541016},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5446237921714783},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5339077115058899},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5183285474777222},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.4742162227630615},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3324672281742096}],"mesh":[{"descriptor_ui":"D000068896","descriptor_name":"Canagliflozin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000068900","descriptor_name":"Sitagliptin Phosphate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077203","descriptor_name":"Sodium-Glucose Transporter 2 Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005960","descriptor_name":"Glucosides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005960","descriptor_name":"Glucosides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005960","descriptor_name":"Glucosides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008078","descriptor_name":"Cholesterol, LDL","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011719","descriptor_name":"Pyrazines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011719","descriptor_name":"Pyrazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011719","descriptor_name":"Pyrazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015992","descriptor_name":"Body Mass Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019984","descriptor_name":"Quality Indicators, Health Care","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D044469","descriptor_name":"Racial Groups","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:24512193","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24512193","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American journal of managed care","raw_type":"Clinical Trial, Phase III"},{"id":"mag:2416610729","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24512193","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W167074208","https://openalex.org/W2029430168","https://openalex.org/W2500481180","https://openalex.org/W1777507583","https://openalex.org/W2038270027","https://openalex.org/W2622984285","https://openalex.org/W2472629762","https://openalex.org/W2793207362","https://openalex.org/W2762463406","https://openalex.org/W1982905493"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"evaluate":[2],"attainment":[3,289],"of":[4,98,108,128,178,197,231,255,261,290],"diabetes-related":[5,62,294],"quality":[6,63,113,126,295],"measures":[7,64,114,127,296],"with":[8,20,52,94,149,172,180,224,244,257,272,283,298,301],"canagliflozin,":[9],"a":[10,35,92,95,195,203,215,258],"sodium":[11],"glucose":[12],"cotransporter":[13],"2":[14,22],"inhibitor,":[15],"versus":[16,174,226,246],"sitagliptin":[17,47,302],"in":[18,50,87,252],"patients":[19,51,109,124,141,152,179,193,232,256,271,281,299],"type":[21],"diabetes":[23],"mellitus":[24],"(T2DM).":[25],"STUDY":[26],"DESIGN:":[27],"This":[28],"post":[29],"hoc":[30],"analysis":[31],"included":[32],"data":[33],"from":[34,212],"52-week,":[36],"randomized,":[37],"double-blind,":[38],"phase":[39],"3":[40],"study":[41,269],"comparing":[42],"canagliflozin":[43,173,225,245,284],"300":[44,285],"mg":[45,49,286],"and":[46,60,82,91,138,202,214,241,292],"100":[48,186,303],"T2DM":[53,273],"on":[54,66,238,274],"metformin":[55,275],"plus":[56,276],"sulfonylurea.":[57],"METHODS:":[58],"Individual":[59],"composite":[61,234,293],"based":[65,237],"glycated":[67],"hemoglobin":[68],"(A1C),":[69],"blood":[70],"pressure":[71],"(BP),":[72],"low-density":[73],"lipoprotein":[74],"cholesterol":[75],"(LDL-C)":[76],"level,":[77],"body":[78,83],"mass":[79],"index":[80],"(BMI),":[81],"weight":[84,210],"were":[85,250],"assessed":[86],"the":[88,106,253],"overall":[89],"population":[90],"subgroup":[93,254],"baseline":[96,259],"BMI":[97,196,216,260],"at":[99,198,221,262],"least":[100,199,263],"25":[101,200,264],"kg/m\u00b2.":[102,265],"RESULTS:":[103],"At":[104,119],"baseline,":[105,213],"proportion":[107,177,230],"meeting":[110],"criteria":[111],"for":[112],"was":[115,188],"similar":[116,189],"between":[117,190],"groups.":[118,191],"week":[120,222],"52,":[121,223],"more":[122],"canagliflozin-treated":[123],"achieved":[125,153,233],"an":[129,143,181],"A1C":[130,144],"less":[131,135,156,161,167,184,217],"than":[132,136,146,157,162,168,185,205,218],"8%":[133],"or":[134,166],"7%,":[137],"fewer":[139],"canagliflozintreated":[140],"had":[142,194],"greater":[145,204,229],"9%,":[147],"compared":[148,297],"sitagliptin.":[150,175,227,247],"More":[151,192],"BP":[154],"measurement":[155],"140/90":[158],"mm":[159,164,170],"Hg,":[160,165],"140/80":[163],"130/80":[169],"Hg":[171],"The":[176],"LDL-C":[182,242],"level":[183,243],"mg/dL":[187],"kg/m\u00b2":[201,220],"10":[206],"lb":[207],"(4.5":[208],"kg)":[209],"loss":[211],"30":[219],"A":[228],"end":[235],"points":[236],"A1C,":[239],"BP,":[240],"Similar":[248],"results":[249],"observed":[251],"CONCLUSION:":[266],"In":[267],"this":[268],"involving":[270],"sulfonylurea,":[277],"after":[278],"52":[279],"weeks,":[280],"treated":[282,300],"demonstrated":[287],"better":[288],"individual":[291],"mg.":[304]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2416610729","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":3}],"updated_date":"2026-11-15T12:55:33.944570","created_date":"2016-06-24T00:00:00"}
